{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:11Z","timestamp":1707525011415},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,22]]},"DOI":"10.7759\/cureus.40807","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T17:01:18Z","timestamp":1687453278000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Amyloidosis in the Setting of a Sarcomatous Pericardial Mass"],"prefix":"10.7759","author":[{"given":"Khaled","family":"Deeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoliy","family":"Korzhuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz MA","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, et al.. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015, 66:2451-66. 10.1016\/j.jacc.2015.09.075","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-10-S1-O10","article-title":"Analysis of disease progression in patients with transthyretin cardiac amyloidosis","volume":"10","author":"Gilmore JD","year":"2015","unstructured":"Gilmore JD, Maurer MS, Vest J, et al.. Analysis of disease progression in patients with transthyretin cardiac amyloidosis. Orphanet J Rare Dis. 2015, 10:O10. 10.1186\/1750-1172-10-S1-O10","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","unstructured":"Transthyretin amyloid cardiomyopathy (ATTR-CM). (2022). Accessed. January 14, 2023: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK574531\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore JD","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al.. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016, 133:2404-12. 10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2017.07.113","article-title":"A survival analysis of subjects with transthyretin amyloid cardiomyopathy from the transthyretin amyloidosis outcomes survey","volume":"23","author":"Grogan M","year":"2017","unstructured":"Grogan M, Dispenzieri A, Carlsson M, et al.. A survival analysis of subjects with transthyretin amyloid cardiomyopathy from the transthyretin amyloidosis outcomes survey. J Card Fail. 2017, 23:41. 10.1016\/j.cardfail.2017.07.113","journal-title":"J Card Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-018-1931-5","article-title":"Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report","volume":"12","author":"Yamamoto H","year":"2018","unstructured":"Yamamoto H, Hashimoto T, Kawamura S, Hiroe M, Yamashita T, Ando Y, Yokochi T. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. J Med Case Rep. 2018, 12:370. 10.1186\/s13256-018-1931-5","journal-title":"J Med Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173086","article-title":"Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - report from the Transthyretin Amyloidosis Outcome Survey (THAOS)","volume":"12","author":"Kristen AV","year":"2017","unstructured":"Kristen AV, Maurer MS, Rapezzi C, Mundayat R, Suhr OB, Damy T. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - report from the Transthyretin Amyloidosis Outcome Survey (THAOS). PLoS One. 2017, 12:e0173086. 10.1371\/journal.pone.0173086","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/13506120600877136","article-title":"Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?","volume":"13","author":"Rapezzi C","year":"2006","unstructured":"Rapezzi C, Perugini E, Salvi F, et al.. Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?. Amyloid. 2006, 13:143-53. 10.1080\/13506120600877136","journal-title":"Amyloid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ahg.12101","article-title":"Asp58Ala is the predominant mutation of the TTR gene in Korean patients with hereditary transthyretin-related amyloidosis","volume":"79","author":"Jang MA","year":"2015","unstructured":"Jang MA, Lee GY, Kim K, et al.. Asp58Ala is the predominant mutation of the TTR gene in Korean patients with hereditary transthyretin-related amyloidosis. Ann Hum Genet. 2015, 79:99-107. 10.1111\/ahg.12101","journal-title":"Ann Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601685","article-title":"Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell","volume":"26","author":"Sato T","year":"2007","unstructured":"Sato T, Susuki S, Suico MA, et al.. Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell. EMBO J. 2007, 26:2501-12. 10.1038\/sj.emboj.7601685","journal-title":"EMBO J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin\u00a0cardiac amyloidosis and\u00a0risk stratification using a novel\u00a0staging system","volume":"68","author":"Grogan M","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA, et al.. Natural history of wild-type transthyretin\u00a0cardiac amyloidosis and\u00a0risk stratification using a novel\u00a0staging system. J Am Coll Cardiol. 2016, 68:1014-20. 10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore JD","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M, et al.. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018, 39:2799-806. 10.1093\/eurheartj\/ehx589","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2018.05.011","article-title":"PET in the diagnostic management of soft tissue sarcomas of musculoskeletal origin","volume":"13","author":"Katal S","year":"2018","unstructured":"Katal S, Gholamrezanezhad A, Kessler M, Olyaei M, Jadvar H. PET in the diagnostic management of soft tissue sarcomas of musculoskeletal origin. PET Clin. 2018, 13:609-21. 10.1016\/j.cpet.2018.05.011","journal-title":"PET Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-011-0095-1","article-title":"Imaging spectrum in soft tissue sarcomas","volume":"2","author":"Aga P","year":"2011","unstructured":"Aga P, Singh R, Parihar A, Parashari U. Imaging spectrum in soft tissue sarcomas. Indian J Surg Oncol. 2011, 2:271-9. 10.1007\/s13193-011-0095-1","journal-title":"Indian J Surg Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/27487871","article-title":"MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity","volume":"85","author":"Chung WJ","year":"2012","unstructured":"Chung WJ, Chung HW, Shin MJ, et al.. MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity. Br J Radiol. 2012, 85:e831-6. 10.1259\/bjr\/27487871","journal-title":"Br J Radiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4274\/mirt.galenos.2020.05657","article-title":"Metabolic characterization of anterior mediastinal masses by (18)F-FDG PET\/CT","volume":"29","author":"Ko\u00e7 ZP","year":"2020","unstructured":"Ko\u00e7 ZP, \u00d6zcan PP, Ayan E, Bozdo\u011fan Arpac\u0131 R. Metabolic characterization of anterior mediastinal masses by (18)F-FDG PET\/CT. Mol Imaging Radionucl Ther. 2020, 29:105-11. 10.4274\/mirt.galenos.2020.05657","journal-title":"Mol Imaging Radionucl Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.3.791","article-title":"Postoperative nomogram for 12-year sarcoma-specific death","volume":"20","author":"Kattan MW","year":"2002","unstructured":"Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002, 20:791-6. 10.1200\/JCO.2002.20.3.791","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2019.1693359","article-title":"Causes of AA amyloidosis: a systematic review","volume":"27","author":"Brunger AF","year":"2020","unstructured":"Brunger AF, Nienhuis HL, Bijzet J, Hazenberg BP. Causes of AA amyloidosis: a systematic review. Amyloid. 2020, 27:1-12. 10.1080\/13506129.2019.1693359","journal-title":"Amyloid"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Secondary, AA, amyloidosis","volume":"44","author":"Papa R","year":"2018","unstructured":"Papa R, Lachmann HJ. Secondary, AA, amyloidosis. Rheum Dis Clin North Am. 2018, 44:585-603.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09776-3","article-title":"Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement","volume":"24","author":"Rigopoulos AG","year":"2019","unstructured":"Rigopoulos AG, Ali M, Abate E, et al.. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Heart Fail Rev. 2019, 24:521-33. 10.1007\/s10741-019-09776-3","journal-title":"Heart Fail Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/156887-cardiac-amyloidosis-in-the-setting-of-a-sarcomatous-pericardial-mass","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:02Z","timestamp":1707508742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/156887-cardiac-amyloidosis-in-the-setting-of-a-sarcomatous-pericardial-mass"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.40807","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}